These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6256002)

  • 21. Involvement of cyclic AMP-dependent protein kinase on the phosphorylase kinase inhibition by glucose-6-phosphate in adipose tissue extracts.
    Ruiz G; Sobrino F; Roca B; Goberna R
    Horm Metab Res; 1986 Jan; 18(1):18-21. PubMed ID: 3005147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine potentiates lutropin-stimulated cyclic AMP production and inhibits lutropin-induced desensitization of adenylate cyclase in rat Leydig tumour cells.
    Dix CJ; Habberfield AD; Cooke BA
    Biochem J; 1985 Aug; 230(1):211-6. PubMed ID: 2996491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eritadenine: a new tool for investigation of the adenosine P site in plasma membranes of rat fat cells.
    Söchtig E; Trost T
    Pharmacology; 1981; 23(2):82-90. PubMed ID: 6273944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue levels, source, and regulation of 3'-AMP: an intracellular inhibitor of adenylyl cyclases.
    Bushfield M; Shoshani I; Johnson RA
    Mol Pharmacol; 1990 Dec; 38(6):848-53. PubMed ID: 2174505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of adenosine cyclic 3', 5'-monophosphate accumulation in fat cells by adenosine, N6-(phenylisopropyl) adenosine, and related compounds.
    Fain JN
    Mol Pharmacol; 1973 Sep; 9(5):595-604. PubMed ID: 4363014
    [No Abstract]   [Full Text] [Related]  

  • 26. Hormonal inhibition of adenylate cyclase. A crucial role for Mg2+.
    Bockaert J; Cantau B; Sebben-Perez M
    Mol Pharmacol; 1984 Sep; 26(2):180-6. PubMed ID: 6541292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Properties of adenylate cyclase and cyclic nucleotide phosphodiesterase in hamster isolated capillary preparations.
    Nemecek GM
    Biochim Biophys Acta; 1980 Mar; 628(2):125-35. PubMed ID: 6244001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenylate cyclase, guanylate cyclase and cyclic nucleotide phosphodiesterases of guinea-pig cardiac sarcolemma.
    St Louis PJ; Sulakhe PV
    Biochem J; 1976 Sep; 158(3):535-41. PubMed ID: 10895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of adenosine 3',5'-monophosphate and the Ri-receptor Gi-coupled adenylate cyclase inhibitory pathway in the mechanism whereby adrenalectomy increases the adenosine antilipolytic effect in rat fat cells.
    de Mazancourt P; Lacasa D; Giot J; Giudicelli Y
    Endocrinology; 1989 Mar; 124(3):1131-9. PubMed ID: 2465135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the stimulatory effect of adrenaline and prostaglandin E1 on the human fat cell adenylate cyclase by adenosine.
    Kather H; Simon B
    Horm Metab Res; 1980 Apr; 12(4):169-72. PubMed ID: 7390397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin stimulation of cyclic AMP phosphodiesterase is independent from the G-protein pathways involved in adenylate cyclase regulation.
    Weber HW; Chung FZ; Day K; Appleman MM
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):345-54. PubMed ID: 3040818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple mechanisms of growth inhibition by cyclic AMP derivatives in rat GH1 pituitary cells: isolation of an adenylate cyclase-deficient variant.
    Martin TF; Ronning SA
    J Cell Physiol; 1981 Nov; 109(2):289-97. PubMed ID: 6271795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic nucleotide phosphodiesterases of Hyalophora cecropia silkmoth fat body.
    Filburn CR; Karn J; Wyatt GR
    Biochim Biophys Acta; 1977 Mar; 481(1):152-63. PubMed ID: 14689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2'-Deoxyadenosine-3'-monophosphate: a naturally occurring inhibitor of adenylate cyclase in amphibian and mammalian cells.
    Sahyoun N; Schmitges CJ; Siegel MI; Cuatrecasas P
    Life Sci; 1976 Dec; 19(12):1961-9. PubMed ID: 826748
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of proteinase inhibitors on adenylate cyclase.
    McIlroy PJ; Richert ND; Ryan RJ
    Biochem J; 1980 May; 188(2):423-35. PubMed ID: 7396871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term hyperthyroidism modulates adenosine receptors and catalytic activity of adenylate cyclase in adipocytes.
    Rapiejko PJ; Malbon CC
    Biochem J; 1987 Feb; 241(3):765-71. PubMed ID: 3036073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Ns-stimulated human platelet adenylate cyclase by forskolin.
    Watanabe Y; Jakobs KH
    Mol Pharmacol; 1986 Mar; 29(3):258-63. PubMed ID: 3005833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenylate cyclase in bloodstream forms of Trypanosoma (Trypanozoon) brucei sp.
    Martin BR; Voorheis HP; Kennedy EL
    Biochem J; 1978 Oct; 175(1):207-12. PubMed ID: 32875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleotide inhibition of adenyl cyclase activity in fat cell membranes.
    Cryer PE; Jarett L; Kipnis DM
    Biochim Biophys Acta; 1969 May; 177(3):586-90. PubMed ID: 4306842
    [No Abstract]   [Full Text] [Related]  

  • 40. Glucose inhibition of adenylate cyclase in intact cells of Escherichia coli B.
    Peterkofsky A; Gazdar C
    Proc Natl Acad Sci U S A; 1974 Jun; 71(6):2324-8. PubMed ID: 4366761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.